- Division of Basic Sciences, Fred Hutchinson Cancer Center, Howard Hughes Medical Institute, Seattle, WA, United States
During mitosis, cells must spatiotemporally regulate gene expression programs to ensure accurate cellular division. Failures to properly regulate mitotic progression result in aneuploidy, a hallmark of cancer. Entry and exit from mitosis is largely controlled by waves of cyclin-dependent kinase (CDK) activity coupled to targeted protein degradation. The correct timing of CDK-based mitotic regulation is coordinated with the structure and function of microtubules. To determine whether mitotic gene expression is also regulated by the integrity of microtubules, we performed ribosome profiling and mRNA-sequencing in the presence and absence of microtubules in the budding yeast Saccharomyces cerevisiae. We discovered a coordinated translational and transcriptional repression of genes involved in cell wall biology processes when microtubules are disrupted. The genes targeted for repression in the absence of microtubules are enriched for downstream targets of a feed-forward pathway that controls cytokinesis and septum degradation and is regulated by the Cbk1 kinase, the Regulation of Ace2 Morphogenesis (RAM) pathway. We demonstrate that microtubule disruption leads to aberrant subcellular localization of Cbk1 in a manner that partially depends on the spindle position checkpoint. Furthermore, constitutive activation of the RAM pathway in the absence of microtubules leads to growth defects. Taken together, these results uncover a previously unknown link between microtubule function and the proper execution of mitotic gene expression programs to ensure that cell division does not occur prematurely.
Introduction
Mitosis, the process by which genetic information is passed on from one cell to the next, is a highly coordinated and regulated event (McIntosh, 2016). Progression through mitosis is carefully controlled because errors result in aneuploidy, a hallmark of cancer and other diseases (Hanahan and Weinberg, 2011; Holland and Cleveland, 2012). This process is driven by increasing cyclin-dependent kinase (CDK) activity that needs to be reversed to allow mitotic exit. CDK activity is regulated by the Anaphase Promoting Complex (APC), an E3 ubiquitin ligase that targets cyclins for degradation and activates phosphatases such as Cdc14 to reverse CDK phosphorylation (Peters, 2006; Curtis and Bolanos-Garcia, 2019; Lara-Gonzalez et al., 2021). While the roles of kinase and opposing phosphatase activities in mitotic progression are well understood, the contribution of other regulatory mechanisms such as translational control is less well studied. Although translation is globally repressed during mitosis (Prescott and Bender, 1962; Fan and Penman, 1970; Stumpf et al., 2013; Tanenbaum et al., 2015), ribosomes and newly synthesized proteins have been observed to colocalize with the mitotic apparatus, suggesting that specific transcripts are locally translated during mitosis (Roth and Daniels, 1962; Gross and Cousineau, 1963; Stafford et al., 1964; Mangan et al., 1965). In addition, microtubules are important for localized translation during development in metazoans (Das et al., 2021), suggesting a functional link between microtubules and translational regulation. However, it is not known whether there is microtubule-dependent regulation of translation during mitosis. We therefore set out to analyze this in budding yeast, an organism that has been widely used to study cell cycle progression and translation due to its simple genome and ease of genetic manipulation (Hartwell et al., 1973; Hinnebusch, 2005; Altmann and Linder, 2010).
Mitosis in budding yeast is regulated by coordinated signaling pathways that ensure the cell cycle does not progress if microtubule-based processes are disrupted. The spindle assembly checkpoint (SAC) monitors attachments of the mitotic spindle to kinetochores, the large macromolecular complexes that assemble on centromeric DNA (Musacchio and Desai, 2017; Lara-Gonzalez et al., 2021). The SAC signaling cascade prevents the onset of anaphase when there are spindle assembly defects by inhibiting Cdc20, an APC activator. To ensure that chromosomes are accurately delivered to the daughter cell, the mitotic exit network (MEN) coordinates spindle position and orientation with release of the Cdc14 phosphatase from the nucleolus (Hotz and Barral, 2014). If the spindle is misaligned, the spindle position checkpoint inhibits the MEN via a GTPase activating complex called Bub2/Bfa1 (Bloecher et al., 2000; Pereira et al., 2000; Wang et al., 2000). After chromosome segregation, the cell wall must be remodeled to promote cytokinesis. These events are controlled by the regulation of Ace2 transcription factor and polarized morphogenesis (RAM) pathway (Racki et al., 2000; Bidlingmaier et al., 2001; Colman-Lerner et al., 2001; Weiss et al., 2002). RAM signaling is activated by the Ndr/LATS kinase Cbk1 that promotes the transcription of genes involved in cell wall function by phosphorylating the Ace2 transcription factor (Colman-Lerner et al., 2001; Nelson et al., 2003; Sbia et al., 2008). In addition, Cbk1 also promotes the translation of these genes by inhibiting the Ssd1 translational inhibitor (Jansen et al., 2009; Kurischko et al., 2011). To ensure that cell wall remodeling occurs after chromosome segregation, the RAM pathway is inhibited during mitosis by high Cdk1 activity and is then activated during mitotic exit by the Cdc14 phosphatase (Mancini Lombardi et al., 2013).
We set out to test whether there is microtubule-dependent translational regulation during budding yeast mitosis since other mitotic signaling pathways are regulated by the integrity of the microtubule cytoskeleton. Towards this end, we performed ribosome profiling in mitotically arrested budding yeast cells treated with the microtubule destabilizing drug nocodazole. We identified the translational downregulation of a functionally related set of mRNAs upon microtubule disruption and find that many of these mRNAs are also transcriptionally repressed. A subset of the mRNAs are targets of the RAM signaling pathway. Consistent with this, we found that microtubule disruption leads to altered Cbk1 localization in a manner that is partially dependent on the mitotic exit network. Forced activation of the RAM pathway in the presence of microtubule disruption impaired cell growth. Taken together, our data suggest that there is a coordinated program that regulates gene expression when microtubules are disrupted to ensure the accurate coordination of mitotic events.
Materials and methods
Yeast methods and drug treatments
Yeast were standardly cultured in YEP + 1% adenine + 2% glucose at 23°C. Yeast strains were constructed using standard genetic techniques. The auxin inducible degron (AID) system was used as previously described (Nishimura et al., 2009). All strains can be found in Supplementary Table S1. To degrade AID tagged proteins, 500 μM IAA (indole-3-acetic acid; Sigma Aldrich #I3750-5G-A) was added to media. Nocodazole (10 μg/ml in DMSO; Sigma Aldrich #M1404-50MG) was used to depolymerize microtubules. Cell cycle arrests (from auxin or nocodazole) were confirmed via microscopy for each experiment. As a control, DMSO was used at equal volume to amount of nocodazole added. All drug treatments were performed for 2.5 h.
Microscopy
Yeast were cultured in YC +1% Adenine +2% glucose + 1× CSM (Sunrise Science Products #1001-100). Yeast were imaged live on agarose pads (1.3% agarose, 4% glucose) containing 2× concentration of drugs as needed (e.g., 20 μg/ml nocodazole; 1 M auxin). Cells were imaged using a Deltavision Ultra deconvolution high-resolution microscope equipped with a 60× or 100×/1.40 UPlanSApo oil-immersion objective (Olympus). Images were captured using a 16-bit sCMOS detector camara. Cells were imaged with z-stacks through entire cells using 0.2 μm steps. Images were deconvolved using standard settings. Images were processed in FIJI for background subtraction and uniform brightness and contrast adjustments applied to entire images.
RNA extractions and quantitative real-time PCR assay
RNA was purified from 5 ml of culture harvested at OD600 ∼0.8 using a Direct-zol RNA miniprep kit with on-column DNase treatment (Zymo #R2050). 1 μg of RNA was then reverse transcribed using an oligo dT primer (Thermo Fisher Scientific #FERSO132) and Protoscript II (200 μ/μl; New England Biolabs #M0368L) in a 20 μl reaction for 30 min at 50°C. Samples were diluted to 120 μl with dH2O prior to qRT-PCR that was performed on an ABI QuantStudio5 instrument in the Fred Hutchinson Cancer Research Center Genomics Core facility. Genes were amplified using primers listed in Supplementary Table S2. Primers were validated to amplify a single amplicon via melt curve analysis, and quantification was performed using standard curves for each primer set.
Motif discovery and ChIP-seq analysis
Promoters of differentially expressed genes (defined as −500 to +1) were downloaded from the S. cerevisiae promoter database (http://rulai.cshl.edu/SCPD/) and were used as input into HOMER v4.11 findMotifs.pl (Heinz et al., 2010). Genes known to be a part of the Environmental Stress Response (Gasch et al., 2000) were excluded from the analysis.
ChIP-seq data from asynchronous cells for Swi5-TAP, Ace2-TAP, and Swi4-TAP (sample IDs: 18061, 16021 and 12000 respectively) was downloaded from the Yeast Epigenome Project (Rossi et al., 2021). ChIP-seq heatmaps were generated using deeptools (version 3.3.0) (Ramirez et al., 2016) commands “computeMatrix reference-point -b 1000 -a 200—missingDataAsZero” and “plotHeatmap—zMin −1 –zMax 3—sortUsing max—sortRegions descend”.
Ribosome profiling
200 ml (YEP + 1% Adenine + 2% glucose) of an asynchronous culture of SBY14004 was grown at 23°C to OD600 of ∼0.2. Cultures were then treated with 500 μM Indole-3-Acetic Acid and 10 μg/ml nocodazole for 2.5 h. Arrests were confirmed via microscopy. Cultures were then harvested via vacuum filtration onto nitrocellulose membranes and scraped immediately into liquid nitrogen.
Pellets were lysed at 4 °C via vortexing with glass microbeads in 1x lysis buffer (1% Triton-X 100; 0.1% sodium deoxycholate; 20 mM Tris pH 7.5; 150 mM KCl; 15 mM MgCl2; 100 μg/ml cycloheximide; 2 mM PMSF; 1X LPC). Lysates were clarified for 30 min at 16000 rpm at 4°C. Clarified lysates were then snap-frozen in liquid nitrogen until ultra-centrifugation.
10%–50% sucrose gradients in 1× polysome buffer (20 mM Tris pH 7.5; 150 mM KCl; 15 mM MgCl2; 100 μg/ml cycloheximide; 2 mM PMSF; 1X LPC) were made in ultracentrifuge tubes (Seton #NC9863486) with a BioComp Gradient Master and used immediately. 400 μg of RNA was then layered over the gradients and loaded onto an SW41 rotor. Samples were ultracentrifuged at 35000 rpm for 2.5 h at 4°C. Following ultracentrifugation, samples were fractionated at 0.3 mm/s with UV absorbance monitoring at 254 nm (EconoUV monitor).
To generate ribosome profiling sequencing libraries, prior to fractionation, 400 μg of RNA was first treated with 2 μl RNase I (10 U/μL; Lucigen #N6901K) for 45 min at room temperature. After digestion, SUPERase RNA inhibitor was added (200 U; Life Technologies #AM2694). Monosome fractions were then collected as described above. RNA was extracted from monosome fraction with TRIzol (Thermo Fisher Scientific #15-596-018) following manufacturer’s instructions. Ribosome profiling and input mRNA-seq libraries were generated from biological triplicates according to a previously published protocol (McGlincy and Ingolia, 2017). Briefly, 1 μg of RNA was size selected on a precast 15% polyacrylamide TBE-Urea gel (Thermo Fisher Scientific #EC68855BOX) using markers NI801 and NI800 for 26 and 34 bases, respectively. Size selected RNAs were purified from the gel overnight in RNA extraction buffer (300 mM Sodium acetate, pH 5.5; 1 mM EDTA; 0.25% SDS v/v) with rotation at room temperature. The following day, RNA was dephosphorylated with T4 Polynucleotide Kinase (New England Biolabs #M0201L) for 1 h at 37°C. Dephosphorylated RNA was then ligated to pre-adenylated, barcoded linker oligos (NI810, NI811, NI812 for DMSO replicates and NI813, NI814, NI815 for nocodazole replicates) for 3 h at 22°C using T4 Rnl2 (tr) K227Q (New England Biolabs #M0351L). Unligated linkers were then depleted at 30°C for 45 min after addition of 0.5 μl of yeast 5′-deadenylase (10 U/μl; New England Biolabs #M0331S) and 0.5 μl RecJ exonuclease (10 U/μl; Lucigen #RJ411250) directly to ligation reaction. Samples were then pooled and purified over a Zymo Oligo Clean & Concentrator column (Genesee Scientific #11-380) according to manufacturer’s instructions. rRNA was subsequently depleted as previously described (Thompson et al., 2020) using biotinylated oligos oSB6755-oSB6769. rRNA-depleted samples were then reverse transcribed in 20 uL reactions with primer NI802 and Protoscript II (200 U/μl) for 30 min at 50°C. RNA was hydrolyzed by addition of 2.2 μl 1 M sodium hydroxide and incubated at 70°C for 20 min cDNA was purified over a Zymo DNA Clean and concentrator column (Genesee Scientific #11-302). RT products were then size selected on a 15% TBE-UREA gel (Thermo Fisher Scientific #EC68855BOX) and purified overnight in DNA extraction buffer (300 mM NaCl, 10 mM Tris pH 8, 1 mM EDTA) with rotation at room temperature. The following day, DNA was circularized using CircLigase II (100 U/μl; Lucigen #CL9021K) for 1 h at 60°C followed by heat inactivation for 10 min at 80°C. The concentration of circularized libraries was quantified using qRT-PCR and oligos NI827/NI828, with a dilution series of NI803 as a standard curve. Libraries were amplified forward primer NI798 and reverse index primers NI799 and NI822 for 11 PCR cycles. Purified DNA libraries were then sequenced on a single Illumina NextSeq run.
Sequencing analysis
Adapters were trimmed with cutadapt v2.9 (Martin, 2011). Subsequently, DMSO treated versus nocodazole treated samples were demultiplexed based on barcoded oligos NI810-NI815 (NI810, NI811, NI812 for DMSO and NI813, NI814, and NI815 for NOCO) using a custom shell script. Reads mapping to ribosomal RNAs were removed by mapping demultiplexed samples to rRNA reference sequences downloaded from Saccharomyces Genome Database (SGD) using the following bowtie2 (v 2.3.5.1) command: “bowtie2 -q—local -N 1 -L 15 -p 12”. PCR duplicates were then removed from the unaligned reads using fastx_collapser (v. 0.0.13). Deduplicated reads were mapped back to S288C reference genome (“S288C_reference_genome_R64-3-1_20210421”) downloaded from SGD. featureCounts (v. 2.0.1) was used to quantify number of reads mapping to genes using the annotation file “saccharomyces_cerevisiae_R64-3-1_20210421.gff” downloaded from SGD and the following command: “featureCounts -t gene -g ID -s 1”. Count tables were then imported into R (v. 4.0.3) for downstream analysis. DESeq2 (v. 1.30.1) was used to quantify differential total mRNA expression between DMSO and nocodazole conditions and riborex v.2.3.4 (Li et al., 2017) was used to quantify translational regulation between DMSO and nocodazole conditions. A single nocodazole treated total mRNA library was excluded from downstream analysis due to low sequencing depth.
Immunoblotting
Strain SBY20970 was cultured in YEP +1% adenine + 2% glucose at 23°C to an OD600 of ∼0.4, at which point the culture was split into auxin + DMSO or auxin + nocodazole for 2.5 h to an OD600 of ∼0.8. 1 ml of culture from each condition was harvested and yeast were pelleted before being lysed by bead beating pellets in SDS sample buffer. Samples were then separated by SDS-PAGE. For immunoblotting, proteins were then transferred from SDS-PAGE gels onto 0.2 uM nitrocellulose at 4°C for 2 h. Membranes were blocked at room temperature with 5% milk in PBST and incubated overnight in primary antibody at 4°C. The following antibodies were used: Anti-GFP (Living Colors GFP monoclonal antibody; 1:20,000) and anti-PGK1 (Thermofisher clone 22C5D8 monoclonal antibody; 1:10,000). After overnight incubation in primary antibody, membranes were washed 2× with PBST for 15 min and then incubated with secondary antibodies (anti-mouse Igg peroxidase-linked whole secondary antibody, Cytiva; 1:10,000 dilution) for 1 h at room temperature in 5% milk in PBST. Membranes were washed 3× for 5 min in PBST and imaged.
Results
Microtubule disruption leads to translational and transcriptional repression of a subset of genes
To determine if there is translational regulation of mitotic pathways upon microtubule disruption, we performed ribosome profiling on a population of mitotically arrested yeast cells treated with and without the microtubule destabilizing drug nocodazole (Figure 1A). To arrest cells in mitosis, we used strains where the APC activator Cdc20 was fused to an auxin-inducible degron at its endogenous locus (CDC20-AID) (Miller et al., 2016). We simultaneously shifted asynchronous cells into auxin in the presence or absence of nocodazole and then performed ribosome profiling, which uses deep sequencing of ribosome-protected RNA fragments to estimate ribosome occupancy and infer translation of an mRNA (Ingolia et al., 2009). We first determined if nocodazole treatment has a global inhibitory effect on translation, as this has been previously reported to occur in mammalian cells (Prescott and Bender, 1962; Fan and Penman, 1970; Stumpf et al., 2013; Tanenbaum et al., 2015). The polysome profiles of mitotically arrested cells were similar in the presence or absence of nocodazole (Figure 1B), consistent with prior studies of microtubule disruption in yeast that did not detect a global inhibition of translation upon microtubule disruption (Sweet et al., 2007).
FIGURE 1. Ribosome profiling reveals a nocodazole induced translational response. (A) CDC20-AID cells (SBY14004) were split into two conditions and simultaneously treated with auxin to arrest cells in metaphase and either nocodazole or DMSO. Lysates from these populations were used for ribosome profiling and mRNA sequencing. (B) Polysome profiles generated from DMSO (blue) and nocodazole (red) treated cells. y-axis is absorbance at 254 nm and x-axis is millimeters (mm) from top of gradient. (C) Volcano plot of ribosome profiling data. Log2 fold changes of total mRNA-normalized footprint abundance (nocodazole vs. DMSO) are plotted on the x-axis, and negative log10 multiple-test corrected p-values are plotted on the y-axis. Individual genes are represented as black dots, and significantly translationally regulated genes (Wald test, Benjamini Hochberg adjusted p < 0.05) are colored in red. (D) Genome browser tracks of ribosome profiling and mRNA sequencing data for two representative genes. Data from the DMSO control condition is shown in blue and nocodazole condition in shown in red. Aggregate (across all replicates) counts per million are plotted on the y-axis. Genomic coordinates are plotted along the x-axis.
Having observed no broad changes to polysome profiles in cells treated with nocodazole, we next looked for gene-level changes to ribosome occupancy. We identified 18 genes that are negatively regulated at the translational level in response to nocodazole (FDR < 0.05; Figure 1C; Supplementary Figure S1A). In control conditions, these genes were translated at appreciable levels (two representative genes are shown in Figure 1D). However, upon nocodazole treatment, ribosome footprint abundance along these transcripts was dramatically reduced, suggesting that microtubule disruption negatively impacts protein production for these specific genes (Figure 1D). In addition to altered levels of ribosome density along the affected transcripts, we also observed a stark decrease in total mRNA abundance for these genes (Figure 1D). This led us to investigate changes in global gene expression upon nocodazole treatment in the mitotically arrested cells. By analyzing the input mRNA-sequencing libraries generated for ribosome profiling, we identified 71 differentially expressed genes (FDR < 0.05, fold change > 2) (Figure 2A; Supplementary Figure S2A). Of the 18 differentially translated genes we identified via ribosome profiling, 14 are also significantly downregulated at the transcriptional level.
FIGURE 2. Nocodazole treatment induces transcriptional regulation of Ace2 target genes. (A) mRNA-seq data from cdc20-AID (SBY14004) cells treated with DMSO or nocodazole. Altered expression of genes upon nocodazole treatment. Log2 mean counts across all replicates and conditions plotted on the y-axis, with log2 fold change (nocodazole vs. DMSO) plotted on the y-axis. Individual genes are represented as black dots, and differentially expressed genes (Wald test, Benjamini Hochberg adjusted p < 0.05 and fold-change > 2) are colored in red. (B) Motif discovery analysis (HOMER) identification of the top 5 significant transcription factor motifs enriched within promoters of differentially expressed genes. (C) Binding profile and heatmap of Swi5, Ace2, and Swi4 ChIP-seq (Rossi et al., 2021) across the promoters of differentially expressed genes from (A). Each row represents a 1.2 kb window (−1 kb to +0.2 kb) around a given gene’s start codon and heatmap is sorted by maximum ChIP signal for each promoter. (D) Nocodazole induced decrease in gene expression in CDC20-AID cells (SBY14004) treated with auxin and either nocodazole (10 μg/ml; Red) or DMSO (Blue). Cells were simultaneously treated with auxin and drug (left) or were sequentially treated (right). N = 3 independent replicates for each treatment. qRT-PCR quantification of individual gene expression values (SVS1, CLN2, DSE4) were normalized to PGK1 expression values within the same sample and fold change is relative to DMSO controls. Error bars represent standard deviation.
Microtubule disruption alters regulation of Ace2 morphogenesis pathway gene expression
To determine if the affected genes are associated with a certain biological process, we performed Gene Ontology analysis on the translationally and transcriptionally regulated genes (Supplementary Figures 1B, 2B, respectively). Both analyses showed that genes involved in cell wall biology are significantly enriched. To identify transcription factors potentially responsible for the observed changes in gene expression, we performed motif discovery analysis [HOMER; (Heinz et al., 2010)] on the promoters of the differentially expressed genes. Compared to the promoters of all genes, the promoters of the differentially expressed genes are significantly enriched for binding motifs for the RAM pathway transcription factor Ace2 as well as the Swi5, Swi4, Hcm1, and Tec1 transcription factors (Figure 2B). To orthogonally validate this observation, we asked if these transcription factors are known to bind to the promoters of the differentially expressed genes using publicly available ChIP-seq data for Swi5, Ace2, and Swi4 (Rossi et al., 2021). We found that Ace2 and Swi4 bind to a subset these promoters, consistent with their binding motifs being enriched in our dataset (Figure 2C). However, Swi5 did not appear to bind to the promoters of the differentially expressed genes, consistent with prior work demonstrating that despite being paralogs with similar binding motifs, Swi5 and Ace2 target distinct sets of genes (Dohrmann et al., 1992; Doolin et al., 2001).
The enrichment of the Ace2 transcription factor motif within the promoters of the nocodazole-induced differentially expressed genes, coupled with the observation that genes involved in cell wall biology are enriched in our ribosome profiling and mRNA-seq datasets, led us to hypothesize that nocodazole could be affecting the RAM pathway (Racki et al., 2000; Bidlingmaier et al., 2001; Colman-Lerner et al., 2001; Weiss et al., 2002). However, the RAM pathway is not known to be active during metaphase, which is the stage where we harvested cells for ribosome profiling and mRNA sequencing. Because we performed these experiments by simultaneously shifting an asynchronously growing population of cells into auxin and nocodazole until they arrested two and a half hours later, we considered the possibility that the nocodazole-induced effects we detected occurred at a different cell cycle stage prior to the final metaphase arrest. To test this, we performed a quantitative real-time PCR assay (qRT-PCR) to analyze total mRNA levels on three candidate genes (SVS1, CLN2, DSE4) that we detected in our genomic analyses. We compared the initial experimental condition, where asynchronous cells were shifted into auxin and nocodazole simultaneously, to a condition where cells were first arrested in metaphase prior to treating them with nocodazole. Using a qRT-PCR assay, we confirmed the nocodazole-induced decreased expression of the three candidate genes when asynchronous cells were simultaneously shifted into auxin and nocodazole (Figure 2D). In contrast, there was little change in gene expression when nocodazole was added to cells that had been arrested in mitosis first. This suggests that our initial protocol reported on regulation at a cell cycle phase other than metaphase, consistent with the possibility that nocodazole affects the RAM pathway that works upon mitotic exit.
Cbk1 localization is altered by microtubule disruption
The RAM pathway exerts transcriptional and translational control via the Cbk1 kinase that both activates Ace2-mediated transcription and relieves Ssd1 translational inhibition (Figure 3A). Consistent with this, 9 of the 18 translationally altered mRNAs in our dataset were previously demonstrated to be Ssd1 targets (Hose et al., 2020). However, the yeast strain background we used for our experiments is hypomorphic for some Ssd1 functions, making it unclear whether the effect of nocodazole could be mediated by Ssd1 in this strain (Sutton et al., 1991; Kaeberlein and Guarente, 2002; Mir et al., 2009). We therefore tested whether the nocodazole-induced effects on gene expression occurred in a strain background with fully functional Ssd1 (Sutton et al., 1991). There was similar inhibition of gene expression of three candidate genes in both strains, supporting the possibility that RAM signaling can work through the hypomorphic Ssd1 allele in the strain background where we initially performed the ribosome profiling (Supplementary Figure S2C).
FIGURE 3. Cbk1 localization is altered in nocodazole treated cells. (A) Model of Cbk1 signaling pathway controlling transcription and translation of genes involved in cell wall remodeling. (B) Immunoblot with anti-GFP antibodies from whole cell extracts of CDC20-AID arrested cells (SBY20970) treated with DMSO or nocodazole for 2.5 h to analyze Cbk1-GFP levels. Pgk1 is a loading control. (C) Nocodazole diminishes accumulation of Cbk1-3GFP in daughter cells. CDC20-AID cells (SBY20970) were arrested in mitosis and treated with DMSO or nocodazole (10 μg/ml) for 2.5 h and live imaged on agarose pads. Scale bar, 5 μm. Two representative images. (D) Binning of Cbk1-3GFP localization phenotype. N = 3 independent replicates, error bars represent standard deviation. p-value derived from two-tailed Student’s t-test. (E) Nocodazole prevents accumulation of Cbk1-3GFP at the bud neck in late mitosis. CDC20-AID mad3∆ (SBY21032) or CDC2020-AID mad3∆ bub2∆ (SBY21080) strains were arrested in mitosis (auxin) for 2.5 h and then released into media containing DMSO or nocodazole and live-imaged on agarose pads containing DMSO or nocodazole. Scale bar, 5 μm. Two representative images 80 min post-release. (F) Cumulative accumulation of Cbk1-3GFP at bud neck within the population. N = 3 independent replicates, error bars represent standard deviation. Blue = DMSO, Red = nocodazole. p-values derived from two-tailed Student’s t-test.
To determine whether microtubule disruption affects the RAM pathway, we focused on Cbk1 because it regulates both Ace2 and Ssd1. First, we examined total Cbk1 protein levels in mitotically arrested cells with and without nocodazole and found they were the same in both conditions, indicating that any defect in Cbk1 signaling is not due to altered Cbk1 levels (Figure 3B). We next tested whether Cbk1 localization is perturbed upon nocodazole treatment. As mitosis progresses, Cbk1 accumulates in the daughter cell and then re-localizes to the daughter cell nucleus and the bud neck after anaphase (Colman-Lerner et al., 2001; Weiss et al., 2002). The enrichment of Cbk1-GFP in daughter cells was reduced upon nocodazole treatment of metaphase-arrested cells, consistent with altered Cbk1 activity (Figures 3C,D; p = 0.003808, Student’s t-test). To analyze the bud neck localization of Cbk1 after chromosome segregation, we released cells from a cdc20-AID arrest into the presence or absence of nocodazole. These cells were also deleted for the MAD3 spindle checkpoint gene to allow cells to proceed into anaphase in the presence of nocodazole. In control cells, we observed robust Cbk1-3GFP localization to the bud neck in the majority (>85%) of cells within 80 min after release. However, in nocodazole-treated cells, this localization was essentially lost (<15% of cells) (Figures 3E,F). Previous work showed that the Cbk1 interacting protein Mob2 localizes to the bud neck after mitotic exit (Weiss et al., 2002). Because microtubule disruption after metaphase inhibits mitotic exit, we considered the possibility that Cbk1 bud neck localization also requires progression through mitosis. To test this, we deleted BUB2 to allow activation of the mitotic exit network in the presence of nocodazole (Bloecher et al., 2000; Pereira et al., 2000; Wang et al., 2000). Deletion of BUB2 was able to partially rescue the Cbk1-3GFP bud neck localization pattern seen in nocodazole-treated cells (Figure 3F; p = 0.0009921, Student’s t-test), suggesting that mitotic progression allows partial Cbk1 localization to the bud neck. However, it was not fully restored, suggesting that additional mechanisms that are altered by defects in the microtubule cytoskeleton regulate the localization of Cbk1 to the bud neck.
Gene expression in the regulation of Ace2 morphogenesis pathway is altered by microtubule depolymerization
To further explore whether the microtubule-based effects on gene expression are due to altered RAM pathway activity, we considered the two known Cbk1 activities that could be inhibited to alter gene expression, which are 1) activation of the Ace2 transcription factor and 2) inhibition of the Ssd1 translational inhibitor, which also destabilizes mRNA (Jansen et al., 2009). To test whether these activities are required to repress the genes affected by microtubule disruption, we used two pathway mutants: 1) an ACE2-F127V dominant mutant that bypasses the need for Cbk1 regulation and constitutively promotes downstream target gene transcription and 2) an ssd1∆ mutant that promotes translation of target genes even in the presence of Cbk1 inhibition (Racki et al., 2000; Mazanka et al., 2008; Jansen et al., 2009). The dominant ACE2-F127V mutant was not sufficient to rescue total mRNA levels of SVS1, CLN2, or DSE4 upon nocodazole treatment (Figure 4A). We considered that translational repression might be epistatic to transcriptional activity induced through ACE2-F127V because changes in translation can lead to transcript degradation which might be the underlying reason for decreased transcription (Deana and Belasco, 2005; Edri and Tuller, 2014). To test this, we deleted SSD1 and found it was indeed able to partially rescue total mRNA levels of SVS1 and CLN2, and when combined with ACE2-F127V, this rescue was synergistic (Figure 4B). These results are consistent with the repression being regulated at both the transcriptional and translational levels by the RAM pathway. However, despite the rescue of SVS1 and CLN2 expression, we found no alteration of DSE4 levels in the mutant backgrounds (Figure 4B). Together, these data indicate that a subset of genes affected by nocodazole may be the result of altered Cbk1 signaling and that additional unidentified mechanisms also exist.
FIGURE 4. Nocodazole induced regulation of gene expression is mediated by Cbk1 signaling pathway. (A) A dominant allele of ACE2 is not sufficient to rescue nocodazole induced changes in gene expression. WT (SBY21046) and ACE2-F127V (SBY21047) cells were treated with DMSO (Blue) or nocodazole (10 μg/ml; Red). N = 3 independent replicates for each treatment. qRT-PCR quantification of individual gene expression values (SVS1, CLN2, DSE4) were normalized to PGK1 expression values within the same sample and fold change is relative to genotype-matched DMSO controls. Error bars represent standard deviation. Expression levels are not elevated in ACE2-F127V strains compared to WT upon nocodazole treatment (p = 0.99, 0.97, 0.99 for SVS1, CLN2, and DSE4 respectively; two-sample t-test). (B) Deletion of SSD1 partially rescues nocodazole-induced changes in gene expression. WT (SBY21118), ssd1∆ (SBY21138), and ssd1∆ ACE2-F127V (SBY21137) were treated with DMSO (Blue) or nocodazole (10 μg/ml; Red). N = 3 independent replicates for each treatment. qRT-PCR quantification of individual gene expression values (SVS1, CLN2, DSE4) were normalized to PGK1 expression values within the same sample and fold change is relative to genotype-matched DMSO controls. Error bars represent standard deviation. Expression levels are elevated in strains compared to WT upon nocodazole treatment (p < 0.05 for SVS1, CLN2, and DSE4 in both mutant backgrounds; two-sample t-test). (C) Modulation of downstream Cbk1 targets sensitizes cells to the microtubule destabilizing drug benomyl. 5-fold serial dilutions of WT (SBY21118), ACE2-F127V (SBY21119), ssd1∆ (SBY21138), and ssd1∆ ACE2-F127V (SBY21137) were plated onto YPD or YPD benomyl (15 μg/mL) plates and incubated at 23°C for 3 days.
Our finding that microtubule disruption inhibits the expression of genes involved in cell wall biology suggested that this might be important to prevent premature cell separation and G1 entry. If this were true, constitutive expression of these genes in the presence of nocodazole should be deleterious to cells. To test this, we plated serial dilutions of WT, ACE2-F127V, ssd1∆, and ssd1∆ ACE2-F127V cells onto the microtubule drug benomyl and found that dominant activation of this pathway indeed led to benomyl sensitivity (Figure 4C). We attempted to determine if septation timing is altered in this situation by monitoring zymolyase sensitivity but did not obtain reproducible results. Although the underlying mechanism is not yet known, our data identify a role for microtubule integrity in regulating the RAM pathway through signaling pathways that help to ensure the coordination of mitotic events.
Discussion
Regulation of transcription and translation in response to microtubule disruption
Here we report the first global analysis of budding yeast translation in the presence and absence of microtubule disruption. Because we induced a mitotic arrest at the same time we added the microtubule depolymerizing agent, we fortuitously identified a class of genes that are regulated by microtubule integrity after mitotic exit. Supporting this idea, when we arrested cells in metaphase prior to adding the microtubule destabilizer, we did not detect this regulation. The class of genes that are downregulated both transcriptionally and translationally in the absence of microtubules are enriched in cell wall processes. We envision at least two non-mutually exclusive ways in which this coordinated downregulation could take place. First, loss of ribosome density itself could lead to a secondary effect of increased transcript degradation and decay, thus leading to an observed decrease in signal in both ribosome profiling and mRNA sequencing experiments. This phenomenon has been observed in both prokaryotes and eukaryotes (Deana and Belasco, 2005; Edri and Tuller, 2014). A second mechanism that could mediate a coordinated downregulation of transcription and translation of a message is a feed-forward signaling pathway that acts at both levels of gene expression. One such signaling pathway is the RAM pathway that regulates the transcription and translation of genes involved in cell wall remodeling (Racki et al., 2000; Bidlingmaier et al., 2001; Colman-Lerner et al., 2001; Weiss et al., 2002; Jansen et al., 2009). This pathway is controlled by Cbk1 which regulates transcription via Ace2 and translation via Ssd1. Our data support a model in which microtubule disruption mechanistically impedes Cbk1 function, leading to downregulation of transcription of cell wall targets through Ace2 and simultaneous downregulation of translation (and likely mRNA decay/degradation) of these same targets via Ssd1. We hypothesize that this regulatory mechanism exists to prevent premature septation prior to completing mitosis. In support of such a hypothesis is our observation that constitutive activation of this gene expression program becomes detrimental to growth in the presence of microtubule disruption.
The Ssd1 translational inhibitor is highly polymorphic across wild and lab yeast strains (Sutton et al., 1991). In the W303 background wherein our genomic experiments were conducted, SSD1 is prematurely truncated (ssd1-d2), leaving Ssd1 without its functionally annotated RNA binding domain (Uesono et al., 1997). This truncation is widely thought to render Ssd1 non-functional, as ssd1-d2 phenocopies ssd1∆ for some functions (Kaeberlein and Guarente, 2002). However, some ssd1∆ phenotypes, such as zymolyase sensitivity, cellular aggregation, and thermosensitivity, are fully complemented by ssd1-d2 (Mir et al., 2009). In addition, recent structural work demonstrated that Ssd1 binds RNA along the surface of its N-terminus in a region still intact in ssd1-d2 (Bayne et al., 2022). These findings suggest ssd1-d2 is likely at least partially functional. Consistent with this, we detected nocodazole-dependent repression of candidate genes in the S288C background where Ssd1 is wildtype. These results suggest that nocodazole negatively regulates the Cbk1-Ace2-Ssd1 feed forward loop that positively regulates expression of cell wall associated genes.
Although we found evidence for regulation of the Cbk1-Ace2-Ssd1 feed-forward loop by microtubule disruption, additional mechanisms must exist because some genes were not regulated by this pathway, such as DSE4. Consistent with this observation, Ssd1 binds to SVS1 and CLN2 transcripts but not to DSE4 transcripts (Hose et al., 2020). We did identify other transcription factor motifs (e.g., for Swi4, Hcm1) enriched in the promoters of the differentially expressed genes, so it is possible that these transcription factors are also regulated by microtubule disruption. In support of this, it has previously been observed that deletion of SWI4 protects cells against microtubule disruption, indicating that Swi4 and its downstream transcriptional targets may be deleterious in the presence of this stress (Beilharz et al., 2017). Additional translational regulators may also be acting in response to microtubule disruption in parallel to Ssd1. In a survey of RNA binding proteins, several other regulators (e.g., Scp160, Khd1/Hek2, Pub1, Nab6 and Mrn1) were found to have significantly correlated binding profiles with Ssd1 (Hogan et al., 2008). It is possible that one or more of these factors may be acting redundantly with Ssd1 to promote regulation of cell wall encoding messages. Finally, another possible mechanism of regulation could be through P-bodies, cytoplasmic sites of post-transcriptional and translational gene regulation. It was previously observed that chemical or genetic perturbation of microtubule function in yeast led to the formation of P-bodies (Sweet et al., 2007). Understanding if the induction of P-bodies upon microtubule stress, as well as the RNA and protein contents of these P-bodies, is linked to the gene regulation uncovered in this study will help further elucidate the mechanism by which cells respond to microtubule stress.
Microtubule integrity regulates Cbk1 localization and activity
Early in the cell cycle, Cbk1 localizes to sites of polarized growth and active cell wall remodeling (Colman-Lerner et al., 2001; Weiss et al., 2002). As mitosis proceeds, Cbk1 localizes to the daughter cell and then relocalizes to the daughter cell nucleus and the bud neck after mitosis (Colman-Lerner et al., 2001; Weiss et al., 2002). Our data show that Cbk1 localization to the daughter cell and the bud neck is sensitive to disruption of the microtubule cytoskeleton. We did not detect Cbk1 in the daughter nucleus in our experiments, likely due to the transient nature of this localization event. However, it is likely that the altered daughter cell localization results in a defect in Cbk1 nuclear localization, consistent with our finding that there is decreased transcription of Ace2 targets. It is unclear whether microtubules directly regulate Cbk1 localization or whether it is an indirect effect of signaling mechanisms that are activated in response to microtubule defects. Consistent with the latter possibility, Cbk1 localization to the bud neck was partially restored when nocodazole-treated cells were allowed to exit mitosis by inhibiting the spindle position checkpoint. In addition, prolonged mitotic arrest leads to altered Ace2 localization, which may also contribute to altered transcription (Herrero et al., 2020). However, mechanisms in addition to mitotic exit are likely involved in regulating Cbk1 because many nocodazole-treated cells still had defective Cbk1 localization despite activation of the mitotic exit network. One possibility is that the bud neck localization of Cbk1 requires nuclear division, a process that cannot occur without microtubules even when the mitotic exit network is activated. In the future, it will be important to elucidate the underlying mechanisms whereby microtubule integrity regulates Cbk1 localization.
Spatiotemporal regulation of Cbk1 localization suggests that a mechanism of localized translational regulation, a common regulatory paradigm widely conserved across eukaryotes, is important for proper completion of mitosis. In support of such a hypothesis is our observation that constitutive activation of this gene expression program becomes detrimental in the presence of microtubule disruption. We hypothesize that this regulatory mechanism exists to prevent premature septation prior to correct completion of mitosis, which would potentially creating an anucleate daughter cell, a nonreversible and deleterious outcome. In the future, it will be important to further understand the additional regulatory mechanisms that ensure appropriate gene expression throughout mitosis as well as to further elucidate the underlying regulation of the RAM pathway by the microtubule cytoskeleton.
Data availability statement
The data presented in the study are deposited in the SRA repository, accession numbers SRR18277492 and SRR18277493.
Author contributions
CHL and SB conceptually designed experiments, analyzed data, and wrote the manuscript; CHL performed experiments.
Funding
This work was supported by the Fred Hutch/University of Washington Cancer Consortium (P30 CA015704). CHL was supported by the Howard Hughes Medical Institute as a fellow of the Helen Hay Whitney Foundation. SB is an investigator of the Howard Hughes Medical Institute.
Acknowledgments
We are grateful for feedback and critical reading of the manuscript from members of the Biggins lab. We are grateful to Eric Weiss for contributing yeast strains. We would also like to thank Yiting Lim, Cindy Wladyka, Andrew Hsieh, Patrick Nugent, and Rasi Subramaniam for their assistance and advice on ribosome profiling.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2022.989820/full#supplementary-material
References
Altmann, M., and Linder, P. (2010). Power of yeast for analysis of eukaryotic translation initiation. J. Biol. Chem. 285, 31907–31912. doi:10.1074/jbc.R110.144196
Bayne, R. A., Jayachandran, U., Kasprowicz, A., Bresson, S., Tollervey, D., Wallace, E. W. J., et al. (2022). Yeast Ssd1 is A non-enzymatic member of the rnase ii family with an alternative rna recognition site. Nucleic Acids Res. 50, 2923–2937. doi:10.1093/nar/gkab615
Beilharz, T. H., Harrison, P. F., Miles, D. M., See, M. M., Le, U. M., Kalanon, M., et al. (2017). Coordination of cell cycle progression and mitotic spindle assembly involves histone H3 lysine 4 methylation by set1/compass. Genetics 205, 185–199. doi:10.1534/genetics.116.194852
Bidlingmaier, S., Weiss, E. L., Seidel, C., Drubin, D. G., and Snyder, M. (2001). The Cbk1p pathway is important for polarized cell growth and cell separation in Saccharomyces cerevisiae. Mol. Cell. Biol. 21, 2449–2462. doi:10.1128/MCB.21.7.2449-2462.2001
Bloecher, A., Venturi, G. M., and Tatchell, K. (2000). Anaphase spindle position is monitored by the Bub2 checkpoint. Nat. Cell Biol. 2, 556–558. doi:10.1038/35019601
Colman-Lerner, A., Chin, T. E., and Brent, R. (2001). Yeast Cbk1 and Mob2 activate daughter-specific genetic programs to induce asymmetric cell fates. Cell 107, 739–750. doi:10.1016/s0092-8674(01)00596-7
Curtis, N. L., and Bolanos-Garcia, V. M. (2019). The anaphase promoting complex/cyclosome (apc/C): A versatile E3 ubiquitin ligase. Subcell. Biochem. 93, 539–623. doi:10.1007/978-3-030-28151-9_18
Das, S., Vera, M., Gandin, V., Singer, R. H., and Tutucci, E. (2021). Intracellular mrna transport and localized translation. Nat. Rev. Mol. Cell Biol. 22, 483–504. doi:10.1038/s41580-021-00356-8
Deana, A., and Belasco, J. G. (2005). Lost in translation: The influence of ribosomes on bacterial mrna decay. Genes Dev. 19, 2526–2533. doi:10.1101/gad.1348805
Dohrmann, P. R., Butler, G., Tamai, K., Dorland, S., Greene, J. R., Thiele, D. J., et al. (1992). Parallel pathways of gene regulation: Homologous regulators Swi5 and Ace2 differentially control transcription of Ho and chitinase. Genes Dev. 6, 93–104. doi:10.1101/gad.6.1.93
Doolin, M. T., Johnson, A. L., Johnston, L. H., and Butler, G. (2001). Overlapping and distinct roles of the duplicated yeast transcription factors Ace2p and Swi5p. Mol. Microbiol. 40, 422–432. doi:10.1046/j.1365-2958.2001.02388.x
Edri, S., and Tuller, T. (2014). Quantifying the effect of ribosomal density on mrna stability. Plos One 9, E102308. doi:10.1371/journal.pone.0102308
Fan, H., and Penman, S. (1970). Regulation of protein synthesis in mammalian cells. Ii. Inhibition of protein synthesis at the level of initiation during mitosis. J. Mol. Biol. 50, 655–670. doi:10.1016/0022-2836(70)90091-4
Gasch, A. P., Spellman, P. T., Kao, C. M., Carmel-Harel, O., Eisen, M. B., Storz, G., et al. (2000). Genomic expression programs in the response of yeast cells to environmental changes. Mol. Biol. Cell 11, 4241–4257. doi:10.1091/mbc.11.12.4241
Gross, P. R., and Cousineau, G. H. (1963). Synthesis of spindle-associated proteins in early cleavage. J. Cell Biol. 19, 260–265. doi:10.1083/jcb.19.1.260
Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell 144, 646–674. doi:10.1016/j.cell.2011.02.013
Hartwell, L. H., Mortimer, R. K., Culotti, J., and Culotti, M. (1973). Genetic control of the cell division cycle in yeast: V. Genetic analysis of cdc mutants. Genetics 74, 267–286. doi:10.1093/genetics/74.2.267
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., et al. (2010). Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576–589. doi:10.1016/j.molcel.2010.05.004
Herrero, E., Stinus, S., Bellows, E., Berry, L. K., Wood, H., and Thorpe, P. H. (2020). Asymmetric transcription factor partitioning during yeast cell division requires the fact chromatin remodeler and cell cycle progression. Genetics 216, 701–716. doi:10.1534/genetics.120.303439
Hinnebusch, A. G. (2005). Translational regulation of Gcn4 and the general amino acid control of yeast. Annu. Rev. Microbiol. 59, 407–450. doi:10.1146/annurev.micro.59.031805.133833
Hogan, D. J., Riordan, D. P., Gerber, A. P., Herschlag, D., and Brown, P. O. (2008). Diverse rna-binding proteins interact with functionally related sets of rnas, suggesting an extensive regulatory system. PLoS Biol. 6, E255. doi:10.1371/journal.pbio.0060255
Holland, A. J., and Cleveland, D. W. (2012). Losing balance: The origin and impact of aneuploidy in cancer. EMBO Rep. 13, 501–514. doi:10.1038/embor.2012.55
Hose, J., Escalante, L. E., Clowers, K. J., Dutcher, H. A., Robinson, D., Bouriakov, V., et al. (2020). The genetic basis of aneuploidy tolerance in wild yeast. Elife 9, e52063. doi:10.7554/eLife.52063
Hotz, M., and Barral, Y. (2014). The mitotic exit network: New turns on old pathways. Trends Cell Biol. 24, 145–152. doi:10.1016/j.tcb.2013.09.010
Ingolia, N. T., Ghaemmaghami, S., Newman, J. R., and Weissman, J. S. (2009). Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324, 218–223. doi:10.1126/science.1168978
Jansen, J. M., Wanless, A. G., Seidel, C. W., and Weiss, E. L. (2009). Cbk1 regulation of the rna-binding protein Ssd1 integrates cell fate with translational control. Curr. Biol. 19, 2114–2120. doi:10.1016/j.cub.2009.10.071
Kaeberlein, M., and Guarente, L. (2002). Saccharomyces cerevisiae Mpt5 and Ssd1 function in parallel pathways to promote cell wall integrity. Genetics 160, 83–95. doi:10.1093/genetics/160.1.83
Kurischko, C., Kim, H. K., Kuravi, V. K., Pratzka, J., and Luca, F. C. (2011). The yeast Cbk1 kinase regulates mrna localization via the mrna-binding protein Ssd1. J. Cell Biol. 192, 583–598. doi:10.1083/jcb.201011061
Lara-Gonzalez, P., Pines, J., and Desai, A. (2021). Spindle assembly checkpoint Activation and silencing at kinetochores. Semin. Cell Dev. Biol. 117, 86–98. doi:10.1016/j.semcdb.2021.06.009
Li, W., Wang, W., Uren, P. J., Penalva, L. O. F., and Smith, A. D. (2017). Riborex: Fast and flexible identification of differential translation from ribo-seq data. Bioinformatics 33, 1735–1737. doi:10.1093/bioinformatics/btx047
Mancini Lombardi, I., Palani, S., Meitinger, F., Darieva, Z., Hofmann, A., Sharrocks, A. D., et al. (2013). Lre1 directly inhibits the ndr/lats kinase Cbk1 at the cell division site in A phosphorylation-dependent manner. Curr. Biol. 23, 1736–1745. doi:10.1016/j.cub.2013.07.032
Mangan, J., Miki-Noumura, T., and Gross, P. R. (1965). Protein synthesis and the mitotic apparatus. Science 147, 1575–1578. doi:10.1126/science.147.3665.1575
Martin, M. (2011). Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10. doi:10.14806/ej.17.1.200
Mazanka, E., Alexander, J., Yeh, B. J., Charoenpong, P., Lowery, D. M., Yaffe, M., et al. (2008). The ndr/lats family kinase Cbk1 directly controls transcriptional asymmetry. PLoS Biol. 6, E203. doi:10.1371/journal.pbio.0060203
Mcglincy, N. J., and Ingolia, N. T. (2017). Transcriptome-wide measurement of translation by ribosome profiling. Methods 126, 112–129. doi:10.1016/j.ymeth.2017.05.028
Mcintosh, J. R. (2016). Mitosis. Cold Spring Harb. Perspect. Biol. 8, a023218. doi:10.1101/cshperspect.a023218
Miller, M. P., Asbury, C. L., and Biggins, S. (2016). A Tog protein confers tension sensitivity to kinetochore-microtubule attachments. Cell 165, 1428–1439. doi:10.1016/j.cell.2016.04.030
Mir, S. S., Fiedler, D., and Cashikar, A. G. (2009). Ssd1 is required for thermotolerance and hsp104-mediated protein disaggregation in Saccharomyces cerevisiae. Mol. Cell. Biol. 29, 187–200. doi:10.1128/MCB.02271-07
Musacchio, A., and Desai, A. (2017). A molecular view of kinetochore assembly and function. Biol. (Basel) 6 (1), 5. doi:10.3390/biology6010005
Nelson, B., Kurischko, C., Horecka, J., Mody, M., Nair, P., Pratt, L., et al. (2003). Ram: A conserved signaling network that regulates Ace2p transcriptional activity and polarized morphogenesis. Mol. Biol. Cell 14, 3782–3803. doi:10.1091/mbc.e03-01-0018
Nishimura, K., Fukagawa, T., Takisawa, H., Kakimoto, T., and Kanemaki, M. (2009). An auxin-based degron system for the rapid depletion of proteins in nonplant cells. Nat. Methods 6, 917–922. doi:10.1038/nmeth.1401
Pereira, G., Hofken, T., Grindlay, J., Manson, C., and Schiebel, E. (2000). The Bub2p spindle checkpoint links nuclear migration with mitotic exit. Mol. Cell 6, 1–10. doi:10.1016/s1097-2765(05)00017-1
Peters, J. M. (2006). The anaphase promoting complex/cyclosome: A machine designed to destroy. Nat. Rev. Mol. Cell Biol. 7, 644–656. doi:10.1038/nrm1988
Prescott, D. M., and Bender, M. A. (1962). Synthesis of RNA and protein during mitosis in mammalian tissue culture cells. Exp. Cell Res. 26, 260–268. doi:10.1016/0014-4827(62)90176-3
Racki, W. J., Becam, A. M., Nasr, F., and Herbert, C. J. (2000). Cbk1p, A protein similar to the human myotonic dystrophy kinase, is essential for normal morphogenesis in Saccharomyces cerevisiae. Embo J. 19, 4524–4532. doi:10.1093/emboj/19.17.4524
Ramirez, F., Ryan, D. P., Gruning, B., Bhardwaj, V., Kilpert, F., Richter, A. S., et al. (2016). Deeptools2: A next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160–W165. doi:10.1093/nar/gkw257
Rossi, M. J., Kuntala, P. K., Lai, W. K. M., Yamada, N., Badjatia, N., Mittal, C., et al. (2021). A high-resolution protein architecture of the budding yeast genome. Nature 592, 309–314. doi:10.1038/s41586-021-03314-8
Roth, L. E., and Daniels, E. W. (1962). Electron microscopic studies of mitosis in amebae. Ii. The giant ameba pelomyxa carolinensis. J. Cell Biol. 12, 57–78. doi:10.1083/jcb.12.1.57
Sbia, M., Parnell, E. J., Yu, Y., Olsen, A. E., Kretschmann, K. L., Voth, W. P., et al. (2008). Regulation of the yeast Ace2 transcription factor during the cell cycle. J. Biol. Chem. 283, 11135–11145. doi:10.1074/jbc.M800196200
Stafford, D. W., Sofer, W. H., and Iverson, R. M. (1964). Demonstration of polyribosomes after fertilization of the sea urchin egg. Proc. Natl. Acad. Sci. U. S. A. 52, 313–316. doi:10.1073/pnas.52.2.313
Stumpf, C. R., Moreno, M. V., Olshen, A. B., Taylor, B. S., and Ruggero, D. (2013). The translational landscape of the mammalian cell cycle. Mol. Cell 52, 574–582. doi:10.1016/j.molcel.2013.09.018
Sutton, A., Immanuel, D., and Arndt, K. T. (1991). The Sit4 protein phosphatase functions in late G1 for progression into S phase. Mol. Cell. Biol. 11, 2133–2148. doi:10.1128/mcb.11.4.2133
Sweet, T. J., Boyer, B., Hu, W., Baker, K. E., and Coller, J. (2007). Microtubule disruption stimulates P-body formation. Rna 13, 493–502. doi:10.1261/rna.355807
Tanenbaum, M. E., Stern-Ginossar, N., Weissman, J. S., and Vale, R. D. (2015). Regulation of mRNA translation during mitosis. Elife 4. doi:10.7554/eLife.07957
Thompson, M. K., Kiourlappou, M., and Davis, I. (2020). Ribo-Pop: Simple, cost-effective, and widely applicable ribosomal rna depletion. Rna 26, 1731–1742. doi:10.1261/rna.076562.120
Uesono, Y., Toh-E, A., and Kikuchi, Y. (1997). Ssd1p of Saccharomyces cerevisiae associates with RNA. J. Biol. Chem. 272, 16103–16109. doi:10.1074/jbc.272.26.16103
Wang, Y., Hu, F., and Elledge, S. J. (2000). The bfa1/bub2 gap complex comprises A universal checkpoint required to prevent mitotic exit. Curr. Biol. 10, 1379–1382. doi:10.1016/s0960-9822(00)00779-x
Weiss, E. L., Kurischko, C., Zhang, C., Shokat, K., Drubin, D. G., and Luca, F. C. (2002). The Saccharomyces cerevisiae mob2p-cbk1p kinase complex promotes polarized growth and acts with the mitotic exit network to facilitate daughter cell-specific localization of Ace2p transcription factor. J. Cell Biol. 158, 885–900. doi:10.1083/jcb.200203094
Keywords: microtubule, ribosome profiling, RAM pathway, translation, transcription, mitosis, Cbk1
Citation: Lee CH and Biggins S (2022) Microtubule integrity regulates budding yeast RAM pathway gene expression. Front. Cell Dev. Biol. 10:989820. doi: 10.3389/fcell.2022.989820
Received: 08 July 2022; Accepted: 19 August 2022;
Published: 12 September 2022.
Edited by:
Scott C. Schuyler, Chang Gung University, TaiwanReviewed by:
Jorge G. Ferreira, Universidade do Porto, PortugalCarlos Conde, Universidade do Porto, Portugal
Copyright © 2022 Lee and Biggins. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sue Biggins, c2JpZ2dpbnNAZnJlZGh1dGNoLm9yZw==